- Home
- AROW vs NVCT Comparison
AROW vs NVCT Comparison
Compare AROW & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AROW | NVCT |
|---|---|---|
| Founded | 1851 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 727.1M | 617.7M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AROW | NVCT |
|---|---|---|
| Price | $37.06 | $20.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $43.50 | $35.40 |
| AVG Volume (30 Days) | 59.6K | ★ 140.4K |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ 49.72 | N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.57 | N/A |
| Revenue Next Year | $16.41 | N/A |
| P/E Ratio | $25.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.91 | $5.55 |
| 52 Week High | $42.70 | $29.28 |
Technical Indicators
Market Signals| Indicator | AROW | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 37.23 | 46.79 |
| Support Level | $35.58 | $17.98 |
| Resistance Level | $37.88 | $23.15 |
| Average True Range (ATR) | 0.74 | 1.46 |
| MACD | -0.09 | -0.23 |
| Stochastic Oscillator | 11.99 | 36.21 |
Price Performance
Historical ComparisonAbout AROW Arrow Financial Corporation
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.